Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Rafael Amado is See Remarks at Zai Lab. OQRO lists 5 transactions filed with the SEC under this name, the latest on Aug 12, 2025, each linked to the official Form 4.
See Remarks
Disclosures on record
5
Companies involved
1
Zai LabZLAB
5 disclosures · Jan 2025 – Aug 2025 · 5 sold
Aug 8, 2025Sold~$105Kdisclosed Aug 12
DetailsOfficial recordApr 4, 2025Sold~$100Kdisclosed Apr 7
DetailsApr 2, 2025Sold~$271Kdisclosed Apr 3
DetailsOfficial recordMar 17, 2025Sold~$115Kdisclosed Mar 19
DetailsOfficial recordDec 31, 2024Sold~$199Kdisclosed Jan 2
DetailsOfficial recordAs of the latest filing on , Rafael Amado reported holding 42,178 shares of Zai Lab (ZLAB), worth about $1.04M at the last close of $25 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Zai Lab ZLAB | 42,178 | 42K direct | $25 | $1.04M | Aug 8, 2025 |
Is this Rafael Amado’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Rafael Amado has no open-market purchase on record since 2020 across 2 companies. Sales in 5 of the 7 years since 2020.
Rafael Amado reported 0 open-market purchases and 18 sales since 2020; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $591K4×4 trades |
| 2024 | — | $838K5×5 trades |
| 2022 | — | $194K5×5 trades |
| 2021 | — | $387K2×2 trades |
| 2020 | — | $1.01M2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Aug 8, 2025, Rafael Amado reported holding 42,178 shares of Zai Lab (ZLAB). At the last close of $25 on Nov 13, 2026, that is about $1.04M. This is the stake disclosed in filings, not a net worth.
Rafael Amado has no open-market purchase on record since 2020 across 2 companies. Sales in 5 of the 7 years since 2020.
In SEC filings since 2020: no open-market purchase is on record; the latest open-market sale is from 2025.
2 companies: Zai Lab (ZLAB, 2024–2025), Allogene Therapeutics (ALLO, 2020–2022).
Rafael Amado reported 0 open-market purchases and 9 sales here, 2024 to 2025.
Rafael Amado reported 0 open-market purchases and 9 sales here, 2020 to 2022.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
